(Total Views: 436)
Posted On: 07/28/2021 11:33:11 AM
Post# of 153988
I received no letter. Did anyone receive the letter? The SA article I posted is next to worthless. "poor stewardship"; "deeply undervalued". There is no plan, no detail, only vague criticism. If they had the votes, what is the point of such a generic letter?
"Leronlimab is under investigation as a treatment for HIV, breast cancer, solid tumors, NASH, and COVID-19."
Not too shabby for an OTC company. If there is a viable plan to unlock the value in Cytodyn, any sensible investor would listen. This group only throws mud and investors wipe it off their boots. OTOH, NP needs to disclose his own plan for unlocking the value in the company. Playing footsie with the FDA is trying everyone's patience.
"Leronlimab is under investigation as a treatment for HIV, breast cancer, solid tumors, NASH, and COVID-19."
Not too shabby for an OTC company. If there is a viable plan to unlock the value in Cytodyn, any sensible investor would listen. This group only throws mud and investors wipe it off their boots. OTOH, NP needs to disclose his own plan for unlocking the value in the company. Playing footsie with the FDA is trying everyone's patience.
(2)
(0)
